AC3 Prostate Cancer Initiative - Leadership Team

 Dr. Earl Bowen , Jr. is Professor at Bryn Mawr College at the Graduate School of Social Work and Social Research. Dr. Bowen is a seven-year prostate cancer survivor. His current research is a qualitative study of the psycosocial implications of prostate cancer among African American prostate cancer survivors. His substantive specialization is the role of public health in achieving health equity and the translation of research findings into health promotion efforts. He currently serves as a member of the Board of Directors on the Pennsylvania Prostate Cancer Coalition.  

 Dr. Charnita Zeigler-Johnson  is an epidemiologist and Assistant Professor of Medical Oncology at Thomas Jefferson University. Dr. Zeigler-Johnson serves as a Project Director in the Center for Excellence in Disparities at the University of Pennsylvania and research collaborator for the Prostate Genetics Research Study in Senegal, West Africa. Her research focuses on defining prostate cancer risk factors and better understanding racial and socioeconomic disparities in the U.S. and developing countries.  

 Dr. Camille Ragin  is a molecular epidemiologist and Associate Professor of Cancer Prevention and Control at Fox Chase Cancer Center - Temple Health. Dr. Ragin is founder and leader of the African Caribbean Cancer Consortium (AC3) and studies prostate cancer in Black men in the United States, Caribbean and Africa. Her research focuses on identifying molecular and genetic biomarkers that predict prostate cancer risk and outcomes.  

Dr Curtiland Deville  is an Assistant Professor of Radiation Oncology at the Hospital of the University of Pennsylvania. Dr. Deville is clinical Chief of the Genitourinary and Sarcoma Services in the Department of Radiation Oncology and specializes in treating patients with genitourinary malignancies and soft tissue sarcoma. His research focuses on incorporating new imaging and radiation modalities, such as proton therapy, and evaluating treatment outcomes.  

Dr. Stephen Avery  is an Assistant Professor of Radiation Oncology at the Hospital of the University of Pennsylvania. Dr. Avery is Director of the Medical Physics Programs in the School of Arts & Sciences at the University of Pennsylvania. His research focuses on quality assurance and safety in proton therapy treatment delivery and developing strategies with middle to low income countries to address the future of cancer treatment and research.